Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000011.xml
Dtsch Med Wochenschr 2009; 134(16): 835-844
DOI: 10.1055/s-0029-1220235
DOI: 10.1055/s-0029-1220235
CME-Beitrag | Review article
Kardiologie
© Georg Thieme Verlag KG Stuttgart · New York
Myokarditis
MyocarditisFurther Information
Publication History
eingereicht: 14.11.2008
akzeptiert: 2.4.2009
Publication Date:
07 April 2009 (online)
Schlüsselwörter
Myokarditis - Diagnostik - Therapie - MRT - Herzmuskelbiopsie
Keywords
myocarditis - diagnosis - therapy - MRI - myocardiaal biopsy
Literatur
- 1 Abril A, Calamia K T, Cohen M D. The Churg Strauss syndrome: review and update. Semin Arthritis Rheum. 2003; 33 106-114
- 2 Aretz H T, Billingham M E, Edwards W D. et al . Myocarditis. A histopathologic definition and classification. Am J Cardiovasc Pathol. 1987; 1 3-14
- 3 Bardy G H. et al . Amiodarone or an Implantable Cardioverter-Defibrillator for Congestive Heart Failure. N Engl J Med. 2005; 352 225-37
- 4 Baughman K L. Diagnosis of myocarditis: death of Dallas criteria. Circulation. 2006; 113 593-595
- 5 Brilakis E S, Olson L J, Berry G J. et al . Survival outcomes of patients with giant cell myocarditis bridged by ventricular assist devices. Asaio J. 2000; 46 569-572
- 6 Cleland J GF, Daubert J C, Erdmann E. et al . The Effect of Cardiac Resynchronization on Morbidity and Mortality in Heart Failure. N Engl J Med. 2005; 352 1539-1549
- 7 Cooper L T, Baughman K L, Feldman A M. et al . The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology. Circulation. 2007; 116 2216-2233
- 8 Corssmit E P, Trip M D, Durrer J D. Loffler’s endomyocarditis in the ideopathic hypereosinophilic syndrome. Cardiology. 1999; 91 272-276
- 9 D’Ambrosio A, Patti G, Manzoli A. et al . The fate of acute myocarditis between spontaneous improvement and evolution to dilated cardiomyopathy: a review. Heart. 2001; 85 499-504
- 10 Dickstein K, Cohen-Solal A, Filippatos G. et al . ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008. Eur J Heart Fail. 2008; 10 933-989
- 11 Felix S B, Staudt A. Immunoadsorption for treatment of dilated cardiomyopathy. Internist. 2008; 49 51-56
- 12 Frustaci A, Chimenti C, Calabrese F. et al . Immunosuppressive therapy for active lymphocytic myocarditis: virologic and immunologic profile of responders versus non-responders. Circulation. 2003; 107 857-863
- 13 Gutberlet M, Spors B, Thima T. et al . Suspected chronic myocarditis at cardiac MR: diagnostic accuracy and association with immunohistologically detected inflammation and viral persistence. Radiology. 2008; 246 401-409
- 14 Holzmann M, Nicko A, Kuhl U. et al . Complication rate of right ventricular endomyocardial biopsy via the femoral approach: a retrospective and prospective study analyzing 3048 diagnostic procedures over a 11-year period. Circulation. 2008; 118 1722-1728
- 15 Kindermann I, Kindermann M, Kandolf R. et al . Predictors of outcome in patients with suspected myocarditis. Circulation. 2008; 118 639-648
- 16 Kuhl U, Lassner D, Pauschinger M. et al . Prevalence of erythrovirus genotypes in the myocardium of patients with dilated cardiomyopathy. J Med Virol. 2008; 80 1243-1251
- 17 Kuhl U, Noutsias M, Seeberg B. et al . Immunohistological evidence for a chronic intramyocardial inflammatory process in dilated cardiomyopathy. Heart. 1996; 75 295-300
- 18 Kuhl U, Pauschinger M, Bock T. et al . Parvovirus B19 infection mimicking acute myocardial infarction. Circulation. 2003; 108 945-950
- 19 Kuhl U, Pauschinger M, Noutsias M. et al . High prevalence of viral genomes and multiple viral infections in the myocardium of adults with „idiopathic” left ventricular dysfunction. Circulation. 2005; 111 887-893
- 20 Kuhl U, Pauschinger M, Schwimmbeck P L. et al . Interferon-beta treatment eliminates cardiotropic viruses and improves left ventricular function in patients with myocardial persistence of viral genomes and left ventricular dysfunction. Circulation. 2003; 107 2793-2798
- 21 Kuhl U, Schultheiss H P. Treatment of chronic myocarditis with corticosteroids. Eur Heart J. 1995; 16 168-172
- 22 Kuhl U, Seeberg B, Noutsias M. et al . Viral persistence in the myocardium is associated with progressive cardiac dysfunction. Circulation. 2005; 112 1965-1970
- 23 Lauer B, Niederau C, Kühl U. et al . Cardiac Troponin T in Patients With Clinically Suspected Myocarditis. J Am Coll Cardiol. 1997; 30 1354-1359
-
24 Liu P P, Schultheiss H -P.
Myocarditis. In: Peter Libby et al. Braunwald’s heart disease: a textbook of cardiovascular medicine. 8th edition. Saunders Elsevier 2008: 1775ff - 25 Mangin M, Mahrholdt H, Sechtem U. Diagnostik der Myokarditis: Darstellung und Bewertung der verfügbaren Methoden. Dtsch Med Wochenschr. 2006; 131 1228-1234
- 26 Mahrholdt H, Wagner A, Deluigi C C. et al . Presentation, Patterns of Myocardial Damage, and Clinical Course of Viral Myocarditis. Circulation. 2006; 114 1581-90
- 27 Mahrholdt H, Goedecke C, Wagner A. et al . Cardiovascular Magnetic resonance Assessment of Human Myocarditis. Circulation. 2004; 109 1250-1258
- 28 Maron B J, Towbin J A, Thiene G. et al . Contemporary definitions and classification of the cardiomyopathies. Circulation. 2006; 113 1807-16
- 29 Maron B J, Ackerman M J. et al . Task Force 4: HCM and other cardiomyopathies, mitral valve prolapse, myocarditis, and Marfan syndrome. J Am Coll Cardiol. 2005; 45 1340-1345
- 30 Martin J, Sarai K, Schindler M. et al . MEDOS HIA-VAD biventricular assist device for bridge to recovery in fulminant myocarditis. Ann Thorac Surg. 1997; 63 1145-1146
- 31 Mason J W, O’Connell J B, Herskowitz A. A clinical trial of immunosuppressive therapy for myocarditis. The Myocarditis Treatment Trial Investigators. N Engl J Med. 1995; 333 269-275
- 32 Pauschinger M, Bowles N E, Fuentes-Garcia F J. et al . Detection of adenoviral genome in the myocardium of adult patients with idiopathic left ventricular dysfunction. Circulation. 1999; 99 1348-1354
- 33 Pauschinger M, Noutsias M, Lassner D. et al . Inflammation, ECG changes and pericardial effusion: whom to biopsy in suspected myocarditis?. Clin Res Cardiol. 2006; 95 569-583
- 34 Schultheiss H P, Piper C, Sowade O. et al . The effect of subcutaneous treatment with Interferon-Beta-1b over 24 weeks on safety, virus elimination and clinical outcome in patients with chronic viral cardiomyopathy. Circulation. 2008; 118 2312
- 35 Tschope C, Bock C T, Kasner M. et al . High prevalence of cardiac parvovirus B19 infection in patients with isolated left ventricular diastolic dysfunction. Circulation. 2005; 111 879-886
- 36 Why H J, Meany B T, Richardson P J. Clinical and prognostic significance of detection of enteroviral RNA in the myocardium of patients with myocarditis or dilated cardiomyopathy. Circulation. 1994; 89 2582-2589
- 37 Wojnicz R, Nowalany-Kozielska E, Wojciechowska C. et al . Randomized, Placebo-Controlled Study for Immunosuppressive Treatment of Inflammatory Dilated Cardiomyopathy : Two-Year Follow-Up Results. Circulation. 2001; 104 39-45
Prof. Dr. med. M. Pauschinger
Medizinische Klinik 8, Kardiologie, Klinikum Nürnberg
Breslauer Straße 201
90471 Nürnberg
Phone: 0911/398-2990
Fax: 0911/398-2988
Email: matthias.pauschinger@klinikum-nuernberg